ArticleBMC cancer2025
Development of a novel angiogenesis-associated gene model for prognosis prediction in colorectal cancer.
Article in BMC cancer, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
backgroundThe expression of angiogenesis-associated genes affects the development of colorectal cancer (CRC). In this study, we aimed to develop and evaluate a method to predict survival outcomes in patients with CRC.
methodsWe investigated the expression of CRC angiogenesis-associated genes using various public databases and identified diverse molecular subtypes. We built an angiogenesis-associated prediction model to forecast patient survival in CRC using the least absolute shrinkage and selection operator and multifactorial COX regression and confirmed its reliable predictive ability.
resultsThe model accurately reflected tumor microsatellite status, immune cell infiltration, and mutation burden. In addition, the model was significantly correlated with drug sensitivity; thus, it can guide the personalized treatment of tumors. Finally, the status of some prognosis-related genes was verified in clinical samples.
conclusionsThis study identified angiogenesis-associated molecular subtypes of CRC and constructed a prognostic model. This signature may provide a new basis for clinical judgment of patient prognosis and personalized therapy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.